Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.55 CNY
580.07 M CNY
3.32 B CNY
417.68 M
About SHENZHEN SALUBRIS
Sector
CEO
Jie Yan
Headquarters
Shenzhen
Website
Founded
1998
ISIN
CNE100000FW8
FIGI
BBG000NNBT70
Shenzhen Salubris Pharmaceuticals Co., Ltd. engages in the research, development, production, and sale of pharmaceuticals and medical devices. Its products include cardiovascular drugs and medical devices; cephalosporin antibiotics and raw materials; and bone resorption inhibitor drugs. The company was founded on November 3, 1998 and is headquartered in Shenzhen, China.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 002294 is 33.05 CNY — it has increased by 1.60% in the past 24 hours. Watch SHENZHEN SALUBRIS stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SZSE exchange SHENZHEN SALUBRIS stocks are traded under the ticker 002294.
002294 stock has risen by 4.59% compared to the previous week, the month change is a −9.82% fall, over the last year SHENZHEN SALUBRIS has showed a 4.39% increase.
We've gathered analysts' opinions on SHENZHEN SALUBRIS future price: according to them, 002294 price has a max estimate of 42.00 CNY and a min estimate of 32.00 CNY. Watch 002294 chart and read a more detailed SHENZHEN SALUBRIS stock forecast: see what analysts think of SHENZHEN SALUBRIS and suggest that you do with its stocks.
002294 reached its all-time high on May 29, 2018 with the price of 46.32 CNY, and its all-time low was 6.73 CNY and was reached on Sep 10, 2009. View more price dynamics on 002294 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
002294 stock is 4.55% volatile and has beta coefficient of 0.58. Track SHENZHEN SALUBRIS stock price on the chart and check out the list of the most volatile stocks — is SHENZHEN SALUBRIS there?
Today SHENZHEN SALUBRIS has the market capitalization of 36.27 B, it has increased by 4.33% over the last week.
Yes, you can track SHENZHEN SALUBRIS financials in yearly and quarterly reports right on TradingView.
SHENZHEN SALUBRIS is going to release the next earnings report on Apr 1, 2025. Keep track of upcoming events with our Earnings Calendar.
002294 earnings for the last quarter are 0.15 CNY per share, whereas the estimation was 0.13 CNY resulting in a 15.38% surprise. The estimated earnings for the next quarter are 0.14 CNY per share. See more details about SHENZHEN SALUBRIS earnings.
002294 net income for the last quarter is 165.62 M CNY, while the quarter before that showed 143.83 M CNY of net income which accounts for 15.15% change. Track more SHENZHEN SALUBRIS financial stats to get the full picture.
Yes, 002294 dividends are paid annually. The last dividend per share was 0.50 CNY. As of today, Dividend Yield (TTM)% is 1.54%. Tracking SHENZHEN SALUBRIS dividends might help you take more informed decisions.
SHENZHEN SALUBRIS dividend yield was 1.53% in 2023, and payout ratio reached 94.07%. The year before the numbers were 1.52% and 86.21% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 22, 2024, the company has 3.52 K employees. See our rating of the largest employees — is SHENZHEN SALUBRIS on this list?
Like other stocks, 002294 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SHENZHEN SALUBRIS stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SHENZHEN SALUBRIS technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SHENZHEN SALUBRIS stock shows the buy signal. See more of SHENZHEN SALUBRIS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.